Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area
- PMID: 12762644
Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area
Abstract
The aim of the study was to evaluate the correlation between thyroid cancer histotype and incidence rate (IR) and iodine nutrition level in two endemic goiter areas: the districts of Krakow and Nowy Sacz. The suspension of iodine prophylaxis in Poland in 1980 resulted in increased goiter prevalence in schoolchildren and adults and elevated TSH levels in newborns in the early 1990s. Since 1992 a rise in thyroid cancer IR was observed. Thyroid cancer IR in the Krakow population was 2.22 in 1986; 3.62 in 1995 and 6.02 in 2001; in Nowy Sacz: 1.52; 2.59 and 3.88 respectively. In 1986 papillary/follicular cancer ratio in both areas was about 1.0--the value typical of iodine deficient areas. After restoring the obligatory iodine prophylaxis in 1997, a significant decrease in elevated TSH concentration in newborns and urinary iodine concentration increase in schoolchildren were observed. A relative rise in the incidence of papillary thyroid cancer and decrease in follicular cancer, resulting in rise in papillary/follicular thyroid cancer ratio up to 5.9 in 2001 was also observed. Since 1999 no further thyroid cancer IR increase was noted. In conclusion, a significant increase in differentiated thyroid cancer IR was observed in association with the iodine prophylaxis suspension. Changes in thyroid cancer histotypes in 1986-2001 and a significant decrease in incremental rate of differentiated thyroid cancer probably reflect the influence of effective iodine prophylaxis. The significant difference between IR of thyroid cancer incidence in the districts of Krakow and Nowy Sacz may be related to differences in the exposure to radiation after the Chernobyl accident.
Similar articles
-
Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland.J Endocrinol Invest. 2003;26(2 Suppl):63-70. J Endocrinol Invest. 2003. PMID: 12762643
-
[Iodine deficiency and thyroid neoplasms in the Krakow region].Wiad Lek. 2001;54 Suppl 1:163-8. Wiad Lek. 2001. PMID: 12182021 Polish.
-
[Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk].Wiad Lek. 2001;54 Suppl 1:169-75. Wiad Lek. 2001. PMID: 12182022 Polish.
-
[Iodine prophylaxis in Poland in light of the WHO recommendation on reduction of the daily salt intake].Pediatr Endocrinol Diabetes Metab. 2009;15(2):103-7. Pediatr Endocrinol Diabetes Metab. 2009. PMID: 19772817 Review. Polish.
-
Iodine intake and thyroid carcinoma--a potential risk factor.Exp Clin Endocrinol Diabetes. 1998;106 Suppl 3:S38-44. doi: 10.1055/s-0029-1212045. Exp Clin Endocrinol Diabetes. 1998. PMID: 9865553 Review.
Cited by
-
Iodine deficiency a persisting problem: assessment of iodine nutrition and evaluation of thyroid nodular pathology in Portugal.J Endocrinol Invest. 2017 Feb;40(2):185-191. doi: 10.1007/s40618-016-0545-2. Epub 2016 Sep 12. J Endocrinol Invest. 2017. PMID: 27619914
-
Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.Endocr Pathol. 2013 Sep;24(3):125-31. doi: 10.1007/s12022-013-9248-9. Endocr Pathol. 2013. PMID: 23666798
-
Increasing incidence of thyroid cancer: controversies explored.Nat Rev Endocrinol. 2013 Mar;9(3):178-84. doi: 10.1038/nrendo.2012.257. Epub 2013 Jan 29. Nat Rev Endocrinol. 2013. PMID: 23358352
-
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse.Cancers (Basel). 2021 Dec 11;13(24):6230. doi: 10.3390/cancers13246230. Cancers (Basel). 2021. PMID: 34944849 Free PMC article.
-
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.Thyroid Res. 2015 Jun 18;8:8. doi: 10.1186/s13044-015-0020-8. eCollection 2015. Thyroid Res. 2015. PMID: 26146517 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical